Clinical Trial Update: IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the IGEV chemotherapy regimen followed by autologous stem cell transplantation in patients with refractory or relapsed Hodgk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Etoposide (Etoposide)
• Gemcitabine (Gemcitabine)
• IFOSFAMIDE (IFOSFAMIDE)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Fudan University | Conditions: Hodgkin Lymphoma | Phase 2 | Status: UNKNOWN